- Home
- ALLO vs CLPT Comparison
ALLO vs CLPT Comparison
Compare ALLO & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALLO | CLPT |
|---|---|---|
| Founded | 2017 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 452.6M | 467.9M |
| IPO Year | 2018 | 2009 |
Fundamental Metrics
Financial Performance| Metric | ALLO | CLPT |
|---|---|---|
| Price | $1.29 | $10.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 2 |
| Target Price | $9.00 | ★ $23.50 |
| AVG Volume (30 Days) | ★ 6.3M | 661.0K |
| Earning Date | 11-09-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.09 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $36,971,000.00 |
| Revenue This Year | N/A | $32.54 |
| Revenue Next Year | $223.15 | $15.41 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.78 |
| 52 Week Low | $1.04 | $8.27 |
| 52 Week High | $4.46 | $24.98 |
Technical Indicators
Market Signals| Indicator | ALLO | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 37.19 | 49.08 |
| Support Level | $1.22 | $8.61 |
| Resistance Level | $2.22 | $11.90 |
| Average True Range (ATR) | 0.08 | 0.50 |
| MACD | 0.01 | 0.20 |
| Stochastic Oscillator | 43.75 | 97.28 |
Price Performance
Historical ComparisonAbout ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.